Law FirmOpposition Filing Analysis

The comprehensive analysis of Cms Cameron Mckenna Nabarro Olswang opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Cms Cameron Mckenna Nabarro Olswang

Patent NumberTitleApplicantOpposition DateOpposition Company
Modulation Of Ube3A-Ats ExpressionIONIS PHARMACEUTICALSApr 16, 2025CMS CAMERON MCKENNA NABARRO OLSWANG
Methods And Systems For Generating A Sterilized Human Milk ProductIMBJan 23, 2025STRAWMAN
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024CMS CAMERON MCKENNA NABARRO OLSWANG
5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating DepressionGH RESEARCHNov 13, 2024STRAWMAN
Treatment Of Amd Using Aav Sflt-1AVALANCHE AUSTRALIASep 19, 2024STRAWMAN
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024CMS CAMERON MCKENNA NABARRO OLSWANG
Inhibition Of Hsd17B13 In The Treatment Of Liver Disease In Patients Expressing The Pnpla3 I148M VariationREGENERON PHARMACEUTICALSDec 8, 2023STRAWMAN
Methods And Compositions For Efficient Delivery Of Nucleic Acids And Rna-Based AntimicrobialsNORTH CAROLINA STATE UNIVERSITYOct 30, 2023SNIPR BIOME APS
Uses Of Neuregulin In Preventing, Treating Or Delaying Ventricular Arrhythmia, And Composition ThereofZENSUN SHANGHAI SCIENCE AND TECHNOLOGYJan 13, 2023STRAWMAN
Live Cell Constructs For Production Of Cultured Milk Product And Methods Using The SameBIOMILQNov 9, 2022STRAWMAN